About Us
We are on a mission to unlock the therapeutic power of the electrome and deliver non-invasive, precision therapeutics for conditions drugs can’t solve—faster, safer, and at scale.
About Us
We are architecting a new era in medicine by harnessing the body’s own bioelectric language to develop precision therapies that heal without drugs—modulating cellular behavior through targeted electromagnetic signals. Our approach opens entirely new frontiers in treating pain, infection, inflammation, and cancer with non-invasive, programmable interventions that work at the speed of biology and are rooted in science.
At the heart of our breakthrough is the Electrome Platform—an AI-powered system that decodes and optimizes the body’s natural signaling networks. By integrating digital twin modeling, high-throughput wet lab validation, and real-world therapeutic feedback, we rapidly identify and refine novel electroceuticals across a broad spectrum of conditions.
Our team brings together visionary scientists, seasoned medical device experts, marketing and regulatory leaders with a shared goal: to unlock the full therapeutic potential of bioelectric medicine. With a robust IP portfolio, scalable hardware platform, and stepwise FDA path, we are building a new class of medicine—where healing begins with signal, not substance.
Our Team
Ken Mayer
CEO
Founder and former CEO of Safe Health (partnership with Mayo Clinic generated $150M in first 5 years); Serial entrepreneur with 3 exits (combined $180M).
Nev Zubcevik, DO
Chief Medical Officer
Harvard-trained physician driving brain-focused R&D, past CMO of SofPulse, leading innovator in brain MedTech. Experienced CMO leading critical brain-recovery MedTech.
Erik Nilson, PhD
CTO
Biophysicist and former DARPA/DoD advisor with over 14 issued patents, 3 exits, and dozens of peer reviewed publications in major journals focused in the field of bioelectric systems.
Wanni Davis, PhD, MBA
COO
Former Executive Director of Industry Partnerships at Stanford and Innovation Director at Harvard; biotech strategist with 15+ years in translational science, venture development, and commercialization.
Samir S. Awad, MD
Medical Director
Chief of Surgery at Houston VA hospital/Baylor College of Medicine . Expert in FDA strategy, clinical research, and non-invasive therapeutic development across pain, wound, and edema fields.
Shari Nastasi, PharmD
Chief Marketing Officer
Neuroimmunology expert with 30+ years advancing brain and immune health therapies. Certified in Neurology, Immunology, Nutrition, and Pharmacogenomics. Published in encephalopathy, brain trauma, and immunology research.
Our Guiding Principals
Lead with Biology to Improve Chemistry
We create therapies that work with the body’s native electrical systems—targeting the root cause, not just the symptoms, through precision bioelectric signaling.
Prove It or Don’t Ship It
Every therapy we develop must be grounded in rigorous science, validated by data, and deliver measurable outcomes—no hype, just evidence.
Engineer for Impact
From discovery to deployment, we build technologies that scale—so the right therapy can reach the right patient, at the right time, anywhere in the world.
Let’s Join Forces to Transform the Future of Medicine
We partner across sectors to bring breakthrough therapies to life—accelerating discovery, access, and real-world impact through science-driven collaboration. Whether you’re a researcher, nonprofit, government agency, payer, or global pharma, we would love to hear from you.
